References
Nucci M, Anaissie EJ, Queiroz-Telles F et al (2003) Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 98:315–319
Wykoff CC, Flynn HW, Miller D et al (2008) Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology 115:1501–1507. https://doi.org/10.1016/j.ophtha.2008.02.027
Nucci M, Garnica M, Gloria AB et al (2013) Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil. Clin Microbiol Infect 19:745–751. https://doi.org/10.1111/1469-0691.12002
Ferrer C, Alio J, Rodriguez A et al (2005) Endophthalmitis caused by Fusarium proliferatum. J Clin Microbiol 243:5372–5375
Al-Hatmi AMS, Bonifaz A, Ranque S et al (2017) Current antifungal treatment of fusariosis. Int J Antimicrob Agents 51:326–332. https://doi.org/10.1016/j.ijantimicag.2017.06.017
Issam IR, Ray YH, Raoul H et al (2006) Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis 42:1938–2403
Perfect JR, Marr KA, Walsh TJ et al (2003) Voriconazole treatment for less common, emerging, or refractory fungal infections. Clin Infect Dis 36:1122–1131
Martínes-Vázquez C, Fernández-Ulloa J, Bordón J et al (1998) Candida albicans endophthalmitis in brown heroin addicts: response to early vitrectomy preceded and followed by antifungal therapy. Clin Infect Dis 27:1130–1133
Rizzelo I, Castagnetti P, Toschi PG et al (2017) Fusarium solani endophthalmitis in a patient with acute lymphocytic leukemia. Mycoses. https://doi.org/10.1111/myc.12697
Nucci M, Marr KA, Queiroz-Telles F et al (2004) Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis 39:1237–1242
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval
The current paper was approved by the ethics committee.
Informed consent
Unfortunately, the patient was dead at the beginning of the study; therefore, she was unable to sign the informed consent. However, the patient is not identifiable by the document or images.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Corona-Lapuerta, M., Martin-Moro, F., Lario, A. et al. Red eye and visual loss in a bone marrow transplant recipient. Ann Hematol 101, 1591–1592 (2022). https://doi.org/10.1007/s00277-022-04778-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-022-04778-y